Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.3700 -0.0290 (-7.27%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about SciSparc Ltd. - Ordinary Shares < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform December 13, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel December 07, 2023 From SciSparc Ltd Via GlobeNewswire Why Is Clearmind Medicine (CMND) Stock Up 50% Today? December 05, 2023 Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock. Via InvestorPlace Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Defense Dept. Funds Ketamine Study For PTSD Treatment Via Benzinga Why SciSparc Ltd Stock Is Blasting Higher November 24, 2023 SciSparc Ltd. Via Benzinga Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial December 01, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Adopts Limited Duration Shareholder Rights Plan November 28, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment November 28, 2023 From SciSparc Ltd Via GlobeNewswire EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders November 28, 2023 Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy. Via Benzinga What's Going On With SciSparc Shares Today? November 27, 2023 SciSparc Ltd (NASDAQ: SPRC) shares are trading lower Monday. The company announced results for MitoCareX Bio with its drug discovery platform. Via Benzinga SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform November 27, 2023 From SciSparc Ltd Via GlobeNewswire New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder November 24, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today November 22, 2023 U.S. stocks showed a positive trend on Wednesday. The Dow Jones index rose by approximately 184 points, marking an increase of 0.5% to 35,273.03. Via Benzinga Topics Stocks Exposures US Equities Gold Moves Lower; SciSparc Shares Spike Higher November 22, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 175 points on Wednesday. The Dow traded up 0.50% to 35,265 while the NASDAQ rose 0.66% to 14,293.93. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 22, 2023 Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Via Benzinga Crude Oil Falls Sharply; Deere Posts Upbeat Earnings November 22, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Wednesday. The Dow traded up 0.51% to 35,266.35 while the NASDAQ rose 0.59% to 14,284.26. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is PaxMedica (PXMD) Stock Up 57% Today? November 22, 2023 PaxMedica stock is heading higher on Wednesday as a public offering for shares of PXMD closes and the company's shares see heavy trading. Via InvestorPlace Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon November 22, 2023 Over the years, Israel has grown into an international giant in the cannabis industry. Via Benzinga Topics Cannabis Exposures Cannabis Why Is SciSparc (SPRC) Stock Up 20% Today? November 22, 2023 SciSparc stock is rising higher on Wednesday as SPRC investors react to the company announcing plans for a merger after a strategic review. Via InvestorPlace Dow Surges 150 Points; US Jobless Claims Decline Sharply November 22, 2023 U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.43% to 35,239.40 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities Why SciSparc Stock Is Trading Higher Wednesday November 22, 2023 SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company signed a non-binding letter of intent to merge with a Via Benzinga SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel November 22, 2023 From SciSparc Ltd Via GlobeNewswire Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 15, 2023 Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Via Benzinga Why SciSparc Ltd Stock Is Lighting Up November 15, 2023 SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company announced positive results from the Phase IIa clinical trial of its investigational compound for the Via Benzinga Why Is SciSparc (SPRC) Stock Up 47% Today? November 15, 2023 SciSparc stock is rising higher with heavy trading of SPRC shares as investors celebrate positive clinical trial results. Via InvestorPlace SciSparc Celebrates Major Breakthrough: Positive Results Show its Treatment has a Remarkable Impact on Alzheimer's Agitation November 15, 2023 From SciSparc Ltd Via GlobeNewswire FDA-Approved Synthetic THC Trials Show 21% Tic Reduction In Tourette Syndrome Patients November 12, 2023 SciSparc Ltd. (NASDAQ: SPRC), a clinical-stage pharmaceutical company, reported a new Phase IIb trial of SCI-110, a proprietary THC-based medication for Tourette Syndrome (TS) treatment. Via Benzinga SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication November 10, 2023 From SciSparc Ltd Via GlobeNewswire Dow Gains 50 Points; Global Payments Posts Upbeat Earnings October 31, 2023 U.S. stocks turned higher toward the end of trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.15% to 32,978.85 while the NASDAQ rose 0.20% to 12,814.52. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 31, 2023 Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... Via Benzinga Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.